United States · FDA National Drug Code directory
Divalproex Sodium
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 65162-755_5284ecb4-6f0a-4388-8f78-a48e0c0123d6
- Product NDC
- 65162-755
- Form
- TABLET, EXTENDED RELEASE
- Composition / generic term
- Divalproex Sodium
- Labeler
- Amneal Pharmaceuticals LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20150601
- Source listing expiry
- 20271231
Source-listed ingredients
- DIVALPROEX SODIUM — 250 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (65162-755-10) · 65162-755-10
- 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (65162-755-50) · 65162-755-50
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →